Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Intelgenx Technologies Corp (IGX.TO)

Intelgenx Technologies Corp (IGX.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Intelgenx Technologies Corp 6420 Abrams Ville Saint Laurent QC H4S 1Y2 CAN

https://www.intelgenx.com P: 514-331-7440 F: 514-331-0436

Sector:

N/A

INDUSTRY GROUPING:

N/A

Description:

Intelgenx Technologies Corp is an oral drug delivery company. The company is focused on the development and manufacturing of pharmaceutical oral films based on its proprietary VersaFilmTM technology platform. The company focuses on the development of novel oral immediate-release and controlled-release products for the pharmaceutical market. It offers a comprehensive portfolio of pharmaceutical services, including pharmaceutical R&D, clinical monitoring, regulatory support, tech transfer, and manufacturing scale-up, and commercial manufacturing. Its geographical segments are Europe, Canada, and the United States. The company generates the majority of its revenue from Europe.

Key Statistics

Overview:

Market Capitalization, $K 39,850
Shares Outstanding, K 174,658
Annual Sales, $ 1,039 K
Annual Net Income, $ -9,927 K
Last Quarter Sales, $ 174 K
Last Quarter Net Income, $ -4,027 K
60-Month Beta 2.38
% of Institutional Shareholders 0.05%

Growth:

1-Year Return 33.33%
3-Year Return -66.20%
5-Year Return -66.20%
5-Year Revenue Growth -10.65%

Per-Share Information:

Most Recent Earnings -0.02 on 05/15/24
Next Earnings Date 08/12/24
Earnings Per Share ttm -0.06
EPS Growth vs. Prev Qtr 0.00%
EPS Growth vs. Prev Year 0.00%
Dividend Payout Ratio 0.00%

IGX.TO Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % N/A
Return-on-Assets % -130.62%
Profit Margin % -955.44%
Debt/Equity N/A
Price/Sales 29.19
Price/Book N/A
Book Value/Share -0.12
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar